A brief therapy to reduce suicidal thoughts in youth

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project tests a brief therapy module aimed at reducing suicidal ideation among youths aged 12 to 17 who experience anxiety or depression. The study involves a randomized controlled trial comparing a standard safety planning intervention with an additional 'Give to Others' module designed to address feelings of burdensomeness. Participants will be recruited from clinical and community settings and will be assessed for changes in their perceptions of burdensomeness after the intervention. The goal is to provide evidence for a scalable therapeutic approach that can be easily implemented by mental health providers.

Why it matters

Who can join: the full rules

Inclusion Criteria

Adolescents must:

* be between ages 12 and 17 years
* score at or above 4 on the Interpersonal Needs Questionnaire- Burdensomeness Scale
* have a positive screen for suicide risk (i.e., endorsement of suicidal ideation via self-report or parent-report).

Exclusion Criteria

For adolescents to be excluded, they must:

* have cognitive impairment or developmental delay which does not allow for the completion of basic study procedures (i.e., reading and filling out questionnaires; talking to a clinician)
* show imminent risk or a history of hurting themselves or others requiring intensive and restrictive services
* be involved currently in a psychosocial treatment

Where it's running

• FIU Center for Children and Families
  Miami, Florida, United States Recruiting

Study contacts

• Principal investigator: Victor Buitron, PhD — Florida International University
• Study coordinator: Jeremy Pettit, PhD
• Email: jpettit@fiu.edu
• Phone: 305-348-1671

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Multi-layered digital monitoring and pharmacogenomics to prevent suicide in adults with depression

  This study tests whether a digital monitoring system, a digital safety plan, and pharmacogenetic-guided care can reduce suicide re-attempts in adults with depression.

  Recruiting Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Madrid, Madrid · NCT07885722

• Rapid relief of suicidal thoughts with ketamine and a crisis plan in the emergency department

  This study tests whether a single intramuscular dose of ketamine plus a brief Crisis Response Plan helps reduce suicidal thoughts in ED patients who are likely to be admitted.

  Recruiting Phase 2 The University of Texas Health Science Center at San Antonio · Fort Hood, Texas and 1 other locations · NCT07868913

• Recovery-oriented suicide prevention for young people at clinical high risk for psychosis

  This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.

  Recruiting at 2 sites University of California, San Diego · Los Angeles, California and 1 other locations · NCT07756567

• Reward Sensitivity Digital App for Adolescent Suicidal Thoughts

  A smartphone app is tested in teens to see if daily check-ins and mood-building activities can reduce suicidal thoughts and improve mood.

  Recruiting University of Pennsylvania · Philadelphia, Pennsylvania · NCT07661901

• Student Precarity and Psychiatry: How Financial Struggles Relate to Depression and Loneliness

  This observational study looks at whether financial hardship and social isolation are linked to depression, suicidal thoughts, and loneliness among French university students.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris, IDF · NCT07618208

• Ketamine with DBT for suicidality in adults with treatment-resistant depression or bipolar disorder and BPD

  This study tests whether four ketamine infusions plus Dialectical Behavioural Therapy can more quickly reduce suicidal thoughts in adults with Borderline Personality Disorder and treatment-resistant depression or bipolar disorder.

  Recruiting Phase 2 University Health Network, Toronto · Toronto, Ontario · NCT07569198

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.